B. Belleau

4.3k total citations · 1 hit paper
136 papers, 3.3k citations indexed

About

B. Belleau is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, B. Belleau has authored 136 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Organic Chemistry, 68 papers in Molecular Biology and 24 papers in Pharmacology. Recurrent topics in B. Belleau's work include Chemical Synthesis and Analysis (21 papers), Analytical Chemistry and Chromatography (14 papers) and Receptor Mechanisms and Signaling (14 papers). B. Belleau is often cited by papers focused on Chemical Synthesis and Analysis (21 papers), Analytical Chemistry and Chromatography (14 papers) and Receptor Mechanisms and Signaling (14 papers). B. Belleau collaborates with scholars based in Canada, United States and United Kingdom. B. Belleau's co-authors include John V. Burba, Joseph Moran, Gilles Lajoie, N. L. Weinberg, Carlo Melchiorre, J.L. Kraus, B. G. Benfey, Yvon G. Perron, Nghe Nguyen‐Ba and François Lépine and has published in prestigious journals such as Science, Journal of the American Chemical Society and Biochemical and Biophysical Research Communications.

In The Last Decade

B. Belleau

133 papers receiving 3.0k citations

Hit Papers

New convenient reagent for peptide syntheses 1968 2026 1987 2006 1968 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Belleau Canada 33 1.6k 1.5k 377 349 337 136 3.3k
Wolfgang Pfleiderer Germany 39 4.3k 2.7× 3.4k 2.3× 252 0.7× 330 0.9× 236 0.7× 581 7.7k
P. J. Goodford United Kingdom 24 2.5k 1.6× 628 0.4× 284 0.8× 262 0.8× 402 1.2× 61 3.9k
Federico Corelli Italy 34 1.8k 1.1× 2.1k 1.4× 606 1.6× 571 1.6× 260 0.8× 224 3.9k
William J. Greenlee United States 34 2.2k 1.4× 2.0k 1.3× 642 1.7× 338 1.0× 110 0.3× 161 4.5k
Richard Storer United Kingdom 33 2.7k 1.7× 3.9k 2.6× 229 0.6× 203 0.6× 245 0.7× 136 6.2k
N. Van Opdenbosch 3 1.3k 0.8× 931 0.6× 149 0.4× 201 0.6× 334 1.0× 5 2.6k
F. MOHAMADI United States 11 2.1k 1.3× 2.0k 1.3× 152 0.4× 325 0.9× 811 2.4× 14 4.1k
Gianluca Giorgi Italy 36 1.3k 0.8× 2.2k 1.5× 283 0.8× 332 1.0× 386 1.1× 268 4.8k
Drake S. Eggleston United States 30 1.9k 1.2× 1.6k 1.1× 120 0.3× 307 0.9× 376 1.1× 157 4.3k
Michael Rowley Italy 38 1.7k 1.1× 1.6k 1.1× 332 0.9× 175 0.5× 154 0.5× 120 4.0k

Countries citing papers authored by B. Belleau

Since Specialization
Citations

This map shows the geographic impact of B. Belleau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Belleau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Belleau more than expected).

Fields of papers citing papers by B. Belleau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Belleau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Belleau. The network helps show where B. Belleau may publish in the future.

Co-authorship network of co-authors of B. Belleau

This figure shows the co-authorship network connecting the top 25 collaborators of B. Belleau. A scholar is included among the top collaborators of B. Belleau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Belleau. B. Belleau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Belleau, B.. (1997). Avant Walt Disney il y eut Palmer Cox. Érudit (Université de Montréal). 13(48). 40–43.
2.
Mansour, Tarek S., Haolun Jin, Wei Wang, et al.. (1995). Structure-Activity Relationships Among a New Class of Antiviral Heterosubstituted 2′,3′-Dideoxynucleoside Analogues. Nucleosides and Nucleotides. 14(3-5). 627–635. 18 indexed citations
3.
Lemaire, Simon, B. Belleau, & F.B. Jolicoeur. (1994). Agonist and antagonist opioid activity of axial and equatorial conformations of S-methyl- and S-allyl-morphinans. European Journal of Pharmacology. 258(1-2). 111–118. 5 indexed citations
5.
Wainberg, Mark A., Michel L. Tremblay, Ronald Rooke, et al.. (1990). Characterization of Reverse Transcriptase Activity and Susceptibility to Other Nucleosides of AZT‐Resistant Variants of HIV‐1. Annals of the New York Academy of Sciences. 616(1). 346–355. 17 indexed citations
7.
Banville, Jacques, et al.. (1988). Nuclear analogs of β-lactam antibiotics. Synthesis of 6,6-disubstituted acylaminopenems. Canadian Journal of Chemistry. 66(6). 1390–1399. 4 indexed citations
8.
Lajoie, Gilles, et al.. (1986). Productive conformation in the bound state and hydrolytic behavior of thiopeptide analogs of angiotensin-converting enzyme substrates. Journal of the American Chemical Society. 108(1). 182–183. 33 indexed citations
9.
Kraus, Jean‐Louis, et al.. (1984). Cyclic tetrameric clusters of chemotactic peptides as superactive activators of lysozyme release from human neutrophils. Biochemical and Biophysical Research Communications. 124(3). 939–944. 6 indexed citations
10.
Belleau, B., et al.. (1979). 9-Oxobenzomorphans. II. A versatile process for the synthesis of 9-oxo-6,7-benzomorphans. Canadian Journal of Chemistry. 57(14). 1861–1865. 7 indexed citations
11.
Ueda, Yoshibumi, et al.. (1978). Molecular properties of the adrenergic alpha-receptor. I--Structural requirements for specific covalent occupancy by N,N'-bis--(5-aminopentyl)cystamine derivatives.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 33(7). 479–95. 1 indexed citations
12.
Haviv, Fortuna & B. Belleau. (1978). Cyclitol analogs of biological interest. Regioselective nucleophilic substitutions of 1,4-cyclohexadiene bisepoxide and bisepisulfide. Canadian Journal of Chemistry. 56(20). 2677–2680. 7 indexed citations
13.
Belleau, B. & Page W. Morgan. (1974). Clastic binding on the opiate receptor. Journal of Medicinal Chemistry. 17(8). 908–909. 20 indexed citations
14.
Belleau, B., et al.. (1972). Purification and Fractionation of Acetylcholinesterase into Subspecies by Affinity Chromatography on a d-Tubocurarine—Sepharose Column. Molecular Pharmacology. 8(5). 589–593. 4 indexed citations
15.
Roufogalis, Basil D. & B. Belleau. (1969). Inhibition of sodium-potassium activated brain adenosine triphosphatase (Na+ - K+-ATPase) by adrenergic blocking alkylating agents. Life Sciences. 8(17). 911–918. 13 indexed citations
16.
Belleau, B., et al.. (1969). The mechanism of irreversible adrenergic blockade by N-carbethoxydihydroquinolines—model studies with typical serine hydrolases. Biochemical Pharmacology. 18(5). 1039–1044. 72 indexed citations
17.
Belleau, B.. (1967). WATER AS THE DETERMINANT OF THERMODYNAMIC TRANSITIONS IN THE INTERACTION OF ALIPHATIC CHAINS WITH ACETYLCHOLINESTERASE AND THE CHOLINERGIC RECEPTORS*. Annals of the New York Academy of Sciences. 144(2). 705–719. 27 indexed citations
18.
Belleau, B.. (1964). A Molecular Theory of Drug Action Based on Induced Conformational Perturbations of Receptors1. Journal of Medicinal Chemistry. 7(6). 776–784. 81 indexed citations
19.
20.
Belleau, B., Marie Fang, John V. Burba, & Joseph Moran. (1960). THE ABSOLUTE OPTICAL SPECIFICITY OF MONOAMINE OXIDASE. Journal of the American Chemical Society. 82(21). 5752–5754. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026